Загрузка...
Hypertension and incident cardiovascular events following ibrutinib initiation
Ibrutinib is associated with dramatic efficacy against B-cell malignancies. Yet, it has been linked with potentially limiting cardiotoxicity, including emerging reports of profound hypertension (HTN). The long-term incidence, severity, and impact of HTN development with ibrutinib are unknown. Theref...
Сохранить в:
| Опубликовано в: : | Blood |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6887116/ https://ncbi.nlm.nih.gov/pubmed/31582362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000840 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|